First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN.
Martínez-Jañez N, Ezquerra MB, Manso Sanchez LM, Carrasco FH, Torres AA, Morales S, Ortega PT, Gil VLO, Sampedro T, Conejero RA, Calvo-Martinez L, Galve-Calvo E, López R, de la Pena FA, Lopez-Tarruella S, de Araguiz BAHF, Ruiz LB, Cardenas TM, Chacon JI, Antón FM.
Martínez-Jañez N, et al. Among authors: de la pena fa.
Breast Cancer Res Treat. 2024 Apr 1. doi: 10.1007/s10549-024-07287-w. Online ahead of print.
Breast Cancer Res Treat. 2024.
PMID: 38561577